Co-Tareg 320 / 12.5 Mg 14 Tablets

Co-Tareg 320 / 12.5 Mg 14 Tablets

Description:

Co-Tareg 320 / 12.5 mg 14 tablets is a prescription antihypertensive medicine combining valsartan (an angiotensin II receptor blocker – ARB) and hydrochlorothiazide (a thiazide diuretic). It is used for the treatment and long‑term control of high blood pressure (hypertension) in adults when monotherapy is insufficient. By relaxing blood vessels and promoting gentle diuresis, Co-Tareg helps lower blood pressure, reduce cardiovascular risk, and support overall heart and vascular health under medical supervision.

Indications:

• Treatment of essential hypertension (primary high blood pressure) in adults.
• Management of high blood pressure in patients not adequately controlled with valsartan or hydrochlorothiazide alone.
• Helps reduce the risk of hypertension‑related complications such as stroke, heart attack, and kidney damage when used as part of a comprehensive cardiovascular risk‑reduction plan.
• Indicated for patients who require combination therapy with an angiotensin II receptor blocker and a thiazide diuretic.

Active Ingredients / Key Components:

• Valsartan – 320 mg per film‑coated tablet (angiotensin II receptor blocker – ARB).
• Hydrochlorothiazide – 12.5 mg per film‑coated tablet (thiazide diuretic).
• Excipients (inactive ingredients) such as tablet core and coating components are present but specific excipient list and concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

• Use exactly as prescribed by your physician. Do not change the dose or stop treatment without medical advice.
• Typical adult dose: 1 tablet of Co-Tareg 320 / 12.5 mg once daily, preferably at the same time each day. The exact dose and strength are determined by your doctor based on blood pressure response and clinical condition.
• Route of administration: Oral. Swallow the tablet whole with a glass of water. Do not crush or chew.
• May be taken with or without food. Taking it at the same time daily improves adherence.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed tablet.
• Regular blood pressure monitoring and periodic laboratory tests (electrolytes, kidney function) may be required during treatment.
• Duration of use: Long‑term, as directed by your doctor, to maintain blood pressure control and cardiovascular protection.

Clinical Benefits:

• Provides effective blood pressure reduction by combining two complementary mechanisms: vasodilation (valsartan) and mild diuresis (hydrochlorothiazide).
• Helps protect the heart, brain, and kidneys by lowering the risk of complications associated with uncontrolled hypertension.
• Once‑daily dosing supports better treatment adherence and stable 24‑hour blood pressure control.
• May improve symptoms associated with high blood pressure such as headache, dizziness, and fatigue when blood pressure is brought under control.
• Combination therapy can be more effective than increasing the dose of a single agent, potentially with a favorable tolerability profile.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to valsartan, hydrochlorothiazide, other sulfonamide‑derived drugs, or any component of the formulation.
• Contraindicated in pregnancy: medicines acting on the renin‑angiotensin system (such as ARBs) can cause injury and death to the developing fetus. If pregnancy is detected, stop Co-Tareg and contact your doctor immediately.
• Contraindicated during breastfeeding unless specifically advised by a physician.
• Contraindicated in severe renal impairment, anuria, or severe hepatic impairment, and in patients with refractory hypokalemia, hypercalcemia, or symptomatic hyperuricemia/gout related to thiazides.
• Use with caution in patients with kidney disease, liver disease, heart failure, coronary artery disease, aortic or mitral stenosis, primary hyperaldosteronism, or a history of gout or significant electrolyte disturbances.
• May cause electrolyte imbalances (low potassium, low sodium, low magnesium, or high uric acid). Regular monitoring of blood electrolytes and kidney function is recommended.
• Risk of symptomatic hypotension, especially in volume‑depleted patients (e.g., on high‑dose diuretics, low‑salt diet, vomiting, diarrhea). Initiate therapy carefully and monitor blood pressure.
• Use with caution in diabetic patients, especially when combined with other agents that affect the renin‑angiotensin system or diuretics.
• May interact with other medications such as lithium, other antihypertensives, NSAIDs, potassium‑sparing diuretics, potassium supplements, or certain antidiabetic agents. Inform your doctor about all medicines and supplements you are taking.
• Avoid excessive alcohol intake as it may enhance blood pressure‑lowering and dizziness.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as kidney disease, liver disease, heart failure, diabetes, gout, or electrolyte imbalance.
• Not intended to diagnose, treat, cure, or prevent any disease outside its approved medical indications.
• Keep out of reach of children.

Side Effects:

• Common side effects may include dizziness, headache, fatigue, low blood pressure (hypotension), mild gastrointestinal discomfort, or increased urination due to the diuretic component.
• Laboratory changes may include alterations in serum electrolytes (potassium, sodium, magnesium), increased uric acid, or changes in kidney function tests.
• Less common but serious side effects can include severe hypotension, kidney dysfunction, electrolyte disturbances (such as significant hypokalemia or hyponatremia), allergic reactions, or worsening of gout.
• Stop the medication and seek immediate medical attention if you experience signs of a severe allergic reaction (rash, itching, swelling of face/lips/tongue/throat, difficulty breathing), severe dizziness or fainting, irregular heartbeat, muscle weakness, or marked decrease in urine output.
• Report any unusual or persistent side effects to your doctor or pharmacist.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: Prescription antihypertensive medicine (combination of ARB and thiazide diuretic).
• Strength per tablet: valsartan 320 mg + hydrochlorothiazide 12.5 mg.
• Form: Film‑coated tablet.
• Pack size: 14 tablets per pack.
• Intended use: Adult patients under medical supervision for the management of high blood pressure.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.